Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WIPF1 and CHRNA1 antisense RNA 1 (WIPF1-AS1) is a long noncoding RNA gene. Its function, biological significance, and disease relevance have not been characterized in publicly available biomedical databases or literature as of September 2025. Unlike the WIPF1 protein, which regulates actin cytoskeleton and participates in immune cell signaling[1][2], WIPF1-AS1 does not encode a protein and is not recognized as a therapeutic target, receptor, or enzyme[3]. The submitted query may reflect a misinterpretation: it merges a protein (WIPF1) and a noncoding RNA (WIPF1-AS1), which are distinct entities.
None reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WIPF1 and CHRNA1 antisense RNA 1 (WIPF1-AS1).